KDIGO争议会议:肿瘤肾脏病学——理解肾功能损害与实体器官恶性肿瘤及管理肾癌
KDIGO于2018年12月召集全球多学科专家组召开肿瘤肾脏病学争议会议。该报告覆盖肾功能损害与实体器官恶性肿瘤的相关问题,以及肾癌的管理与治疗。报告描述了知识缺口、争议领域和研究优先方向。文章指出CKD患者癌症发病率增加,癌症及其治疗均可导致肾功能受损,肾功能问题会恶化患者结局并降低抗癌治疗充分性,而新型疗法在CKD患者中的耐受性数据常缺乏。
要点
- CKD患者癌症发病率增加,癌症和癌症治疗均可导致肾功能受损。
- 恶性肿瘤背景下的肾脏问题会恶化患者结局并降低抗癌治疗的充分性。
- 肿瘤治疗格局快速变化,新型疗法在CKD患者中的耐受性数据常缺乏。
- 肿瘤患者照护已高度专业化,需要肾内科、肿瘤内科、重症、临床药理/药学、姑息治疗及外科和泌尿科协作。
- KDIGO于2018年12月召开全球多学科争议会议,报告描述知识缺口、争议领域和研究优先方向。
适用人群与场景
- 实体器官恶性肿瘤患者合并肾功能损害或CKD。
- 肾癌患者的管理与治疗。
研究设计与关键结果
- KDIGO于2018年12月召集全球多学科临床与科学专家组召开肿瘤肾脏病学争议会议。
- 报告覆盖肾功能损害与实体器官恶性肿瘤相关问题,以及肾癌的管理与治疗。
- 报告描述了知识缺口、争议领域和研究优先方向。
证据类型、等级与局限
- 证据类型:KDIGO争议会议报告(指南/共识类文件)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 肿瘤患者照护需要肾内科、肿瘤内科、重症、临床药理/药学、姑息治疗以及外科和泌尿科多学科协作。
- 原文指出新型疗法在CKD患者中的耐受性数据常缺乏,属于报告描述的知识缺口,原文未据此给出具体用药推荐。
指南或共识出处
- KDIGO Controversies Conference on onco-nephrology,KDIGO(Kidney Disease: Improving Global Outcomes),2018年12月会议。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
The association between kidney disease and cancer is multifaceted and complex. Persons with chronic kidney disease (CKD) have an increased incidence of cancer, and both cancer and cancer treatments can cause impaired kidney function. Renal issues in the setting of malignancy can worsen patient outcomes and diminish the adequacy of anticancer treatments. In addition, the oncology treatment landscape is changing rapidly, and data on tolerability of novel therapies in patients with CKD are often lacking. Caring for oncology patients has become more specialized and interdisciplinary, currently requiring collaboration among specialists in nephrology, medical oncology, critical care, clinical pharmacology/pharmacy, and palliative care, in addition to surgeons and urologists. To identify key management issues in nephrology relevant to patients with malignancy, KDIGO (Kidney Disease: Improving Global Outcomes) assembled a global panel of multidisciplinary clinical and scientific expertise for a controversies conference on onco-nephrology in December 2018. This report covers issues related to kidney impairment and solid organ malignancies as well as management and treatment of kidney cancer. Knowledge gaps, areas of controversy, and research priorities are described.
参考来源
- Porta C, Bamias A, Danesh FR, et al. KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer. Kidney Int. 2020. PMID: 33126977. doi:10.1016/j.kint.2020.06.046
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。